OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yang Yang, Ke Wang, Hao Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113001-113001
Closed Access | Times Cited: 33

Showing 26-50 of 33 citing articles:

Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction
Lincheng Fang, Jiping Tian, Kaixuan Zhang, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116370-116370
Closed Access | Times Cited: 9

Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties
Romain Regnault, Frédérique Klupsch, Hassiba El-Bouazzati, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3491-3491
Open Access | Times Cited: 2

Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors
Shivanshu Pandey, Balak Das Kurmi, Preeti Patel
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 18, pp. 1765-1781
Closed Access | Times Cited: 2

Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents
Natascha Leleu‐Chavain, Romain Regnault, Hania Ahouari, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3316-3316
Open Access | Times Cited: 4

Molecular docking study of britannin binding to PD-L1 and related anticancer pseudoguaianolide sesquiterpene lactones
Gérard Vergoten, Christian Bailly
Journal of Receptors and Signal Transduction (2021) Vol. 42, Iss. 5, pp. 454-461
Closed Access | Times Cited: 5

Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against pd-1/pd-l1
Pujan Sasmal, P. Prabitha, B. R. Prashantha Kumar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108036-108036
Closed Access

Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
Xiaoyun Li, Qin Zeng, Fengjiao Xu, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1935-1955
Closed Access | Times Cited: 2

Previous Page - Page 2

Scroll to top